Cargando…
Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma
Interleukin-33 (IL-33)/IL-33 receptor (IL-33R, ST2) signaling pathway promotes mammary cancer growth and metastasis by inhibiting anti-tumor immunity. However, the role of IL-33/IL-33R axis in neoangiogenesis and tumor necrosis is not elucidated. Therefore, the aim of this study was to investigate t...
Autores principales: | Milosavljevic, Milos Z., Jovanovic, Ivan P., Pejnovic, Nada N., Mitrovic, Slobodanka L. J., Arsenijevic, Nebojsa N., Simovic Markovic, Bojana J., Lukic, Miodrag L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951275/ https://www.ncbi.nlm.nih.gov/pubmed/26919112 http://dx.doi.org/10.18632/oncotarget.7635 |
Ejemplares similares
-
IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012) -
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016) -
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
por: Jovanovic, Ivan, et al.
Publicado: (2011) -
Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding
por: Jovicic, Nemanja, et al.
Publicado: (2015) -
Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma
por: Zdravkovic, Natasa D, et al.
Publicado: (2014)